Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q1 2021 Financial Results

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its 2021 first quarter financial results and subsequent events. “This was another great quarter for the company as we continued to see strong traction for our brands,” said Brad Rogers, RWB’s chairman & CEO. “We are building on that momentum and working towards finalizing our revised asset purchase of our Michigan investee to bring their revenue, as well as adjusted sales into IFRS revenue format before the end of this current quarter. Once complete, and the expansion of our Florida operations come on stream, we can finally report in our quarterly results the strength of what we have built and accomplished thus far.”

To view the full press release, visit https://cnw.fm/egQMZ

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Creating Brand Loyalty by ‘Doing It Right’

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, has made compliance with regulatory standards for hemp-derived products worldwide one of its main priorities. This has opened doors to outlets for its products while many other CBD companies have struggled. In a June 29 Hemp Barons podcast, HempFusion co-founder and CEO Jason Mitchell and host Joy Beckerman extensively discussed the regulatory journey CBD dietary supplements, as well as OTC cosmetic topicals, have taken under guidance from the U.S. federal government. A recent article quotes Mitchel as saying, “The fact is, it’s really fun to do it right, because it’s challenging. And then when you see the consumer response that they get the result they want, and that you did it correctly . . . they’re going to have a tremendous amount of trust in you and have longevity in their support of your brand . . . and so that’s why we did it. We create this brand loyalty by virtue of doing it right.”

To view the full article, visit https://cnw.fm/x3zgH

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 U.S. states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://cnw.fm/CBDHF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Is Frontrunner in Search for Elusive Prize

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) is well equipped to pursue – and achieve – the quest for consistency and customization that offers value for money to recreational cannabis users. “The company’s unique partnership with Phenome One, recognized as one of Canada’s largest live genetic libraries, allows Pac Roots to focus on selective breeding and preservation,” reads a recent article. “That key partnership, which enables Pac Roots to optimize the genetic makeup of its cannabis plants as well as develop unique strains featuring a variety of beneficial characteristics, established the company as a frontrunner in the search for what the New York Times called an elusive prize: ‘a predictable, reliable product.’ With Phenome One in its corner, along with existing infrastructure, equipment and access to land as well as aligned brands, Pac Roots is ideally positioned to preserve the excellence of its elite strains while also introducing the highest quality strains.”

To view the full article, visit https://cnw.fm/zVJ9E

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners: Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

Green Hygienics (OTCQB: GRYN) has appointed a new senior vice president. David Racz, a seasoned pharmaceutical executive, has been named senior VP of global sales and business development for the innovative, tech-driven company. Racz has garnered extensive experience in the both the pharma and cannabis sectors, having served in global, senior-level positions with well-known pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. At Pfizer, he was vice president of sales and human resources, overseeing the largest expansion in Pfizer’s sales force in history. At SmithKline Beecham, he managed more than 4,000 sales, marketing and R&D employees, who were located in 20 countries throughout Asia, Latin America, Australia, and South Africa. He was also a member of the team that coordinated and managed the transcontinental merger of SmithKline and Beecham. At Novartis, he supervised strategy and resource allocation for the $8 billion health-care company and managed 14,000 global employees. He entered the cannabis market in 2008 when he worked with legislative bodies in Colorado to develop the state’s medical cannabis laws, and starting in 2011, he led a team that applied for and acquired six cannabinoid-related patents, discovered two cannabis chemical structures, built a cannabis DNA library with more than 4,000 different strains and oversaw the early advancement of cannabis genetic engineering for application in large-scale production.

To view the full press release, visit https://cnw.fm/MRPHi

About Green Hygienics Holdings Inc.

Green Hygienics is a California-based innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with consumer packaged goods (“CPG”) and pharmaceutical companies. For more information about the company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Partner with Avaria to Bring Award-Winning KaLaya Brand to LATAM Distribution Network

Flora Growth Corp. (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a non-binding letter of intent (“LOI”) to form a joint venture (“JV”) with Avaria Inc. Canadian-based Avaria is the manufacturer and owner of KaLaya — an award-winning pain cream distributed across Canada. Through the JV, Flora Growth will manage registration, sales and distribution of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will supply finished product. Flora Growth and Avaria will equally divide the profits from the sale of KaLaya products under the JV, increasing the value of Flora’s existing distribution channels. “We are very excited to partner with Avaria to bring their established, award-winning KaLaya brand to our LATAM distribution network. We believe the product will receive a similarly strong reception as it has in Canada,” said Flora Growth CEO and President Luis Merchan. “Moving forward, Flora Lab will work with the Avaria team to produce CBD-infused versions of KaLaya products for distribution across LATAM as well as export into the United States. Given CBD’s association with wellness, KaLaya’s established formulation, and Flora Growth’s low-cost high-quality cannabis, this is a natural partnership we are excited to bring globally.”

To view the full press release, visit https://cnw.fm/vgKPw

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, and its flagship product, Hourglass THC+CBD Patchless Patch Topical Cream, has received an Instagram endorsement from Grammy Award-winning writer, producer and director Damien Matthias, known as ELove. ELove has performed and co-produced with LL Cool J, one of Def Jams Records’ first artists. He also played a key role in launching the careers of Tupac Shakur and John Forte of the Fugees and was integrally involved in the pre-internet marketing team of Def Jam Records, one of the most successful independent labels of all time. “Hourglass, the best thing on the market. You have any kind of discomfort, this right here is filled with CBD, and it actually works. Best thing on the market, no doubt,” said ELove in the Instagram post.

To view the full message, visit https://cnw.fm/tLidf

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — US Surgeon General Calls for End to Marijuana-Related Incarcerations

The war on drugs, which was launched with the noble aim of curbing drug use and defunding criminal enterprises behind the illicit drug trade, is an unmitigated failure. Tens of millions of people have been arrested and incarcerated over the past four decades, breaking up families, ruining lives and leaving the United States with the largest prison population in the world. Minorities, specifically communities of color, bore the brunt of the drug war, and they are still victim to intense policing and harsh sentencing due to drug policies.

Drug reform activists have long been advocating for the end of cannabis-related incarcerations, especially as more states have legalized either medical or recreational cannabis, and the U.S. Surgeon General is of the same opinion. Surgeon General Dr. Vivek Murthy, while talking about a federal marijuana legalization bill circulated by Senate Majority Leader Chuck Schumer, said that it is time America stops imprisoning people for cannabis use. While he didn’t endorse broad commercial legalization, he emphasized that there is no value behind incarcerating individuals for cannabis possession, stating that he thinks it doesn’t “serve anybody well.”

Taking a more neutral stance on cannabis, he pointed out that it has pros and cons, although the hype seems to have outpaced the science. The country will have to let the science guide its efforts towards decriminalizing and legalizing marijuana, he says. While the controversial drug has medicinal properties, it also has potential harms that have to be considered, and putting these two perspectives together will help inform policymakers.

Back in 2015, Murthy, who also served as Surgeon General under former President Barack Obama, pointed out that preliminary evidence showed that cannabis can be helpful against certain medical conditions and symptoms.

However, he later stated in 2018 that the wave of cannabis legalization reform sweeping across America concerned him, especially given how little remains unknown know about marijuana’s effects. The industry has grown a great deal in just a few years, and sellers have taken to making false claims about what their products can do to boost sales. In fact, the FDA has had to send warning letters to several companies to curb this false advertising.

With more states legalizing cannabis, researchers have been able to look into cannabis’ capabilities and its side effects better than ever before. President Joseph Biden, who ran his campaign on cannabis decriminalization among other issues, supports incremental decriminalization and expunging prior cannabis-related infractions from records. However, he still hasn’t acted on these promises since he took office, choosing instead to work on a massive $1.5 trillion infrastructure bill.

The views expressed by the U.S. Surgeon General regarding the futility of sending people to jail because they consume cannabis was realized years back by other countries, including Canada, where a legal marijuana market that gave companies such as Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) space to thrive was created.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are available in the company’s newsroom at http://cnw.fm/PACR

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Three Tips for New Medical Cannabis Patients

Research has found that medical marijuana possesses therapeutic benefits, and with more states across the country legalizing the use of medical marijuana in alleviating and managing symptoms of various indications, it is important to acquaint yourself with what this means for you, especially if you qualify to use medical cannabis.

Most, if not all the states that have legalized its medical use, stipulate that a prescription should be given by a qualified doctor, which helps ensure that the use of medical cannabis doesn’t affect the effectiveness of other medications that are being taken.

Here are a few things new users of medical cannabis should know or do to ensure they stay healthy and safe while using medical cannabis.

Know the conditions eligible for medical cannabis use

Most states have established lists of the conditions or ailments for which eligible people are allowed to use medical cannabis.

The most common conditions eligible for medical cannabis use include:

  • Multiple sclerosis
  • Glaucoma
  • Arthritis
  • Epilepsy
  • Post-traumatic stress disorder
  • Chronic pain
  • Cancer

If your disease isn’t included on the list, you probably won’t receive clearance or get a prescription from your doctor to take medical cannabis. It should be noted, however, that the ailments can differ from state to state, so be sure to check with local medical authorities for confirmation.

Conduct your own research

The market today is filled with different kinds of medical cannabis products, which are not made equally. If you are eligible for medical marijuana use, ensure that you do your own research on these products, centering on manufacturers and products that have a reputation for good quality and performance.

Apart from taking advice from your physician, you can also use the internet for your research. In addition to this, you can talk to other patients who use medical marijuana and ask for their advice on what types of brands and products to trust.

Find out the different types of products available

A prescription from your doctor may not specify the particular product to be used. In most cases, prescriptions only specify the CBD amount and potency that should be in every product you will be using.

While budtenders and curators at the dispensaries may help you choose the right product based on your prescription, it is important that you do your own research on the different products available.

Each medical cannabis product has its pros and cons, with the most common products being THC vapes, marijuana topicals and marijuana edibles. It is important to ask your physician about anything you’re unsure of with regard to your prescription and communicate any uneasiness you may feel to ensure you see the most benefit from your treatment.

Some companies, such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), have taken the added step to develop cannabis-based treatments that they hope will be approved by regulators, such as the FDA, for use by patients even in regions where medical marijuana isn’t legal yet.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Positioned to Benefit from Revised Colombian Regulations, Is Covered by Argus Research Report

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, has announced that new Colombian regulations allow the company to increase revenue both long and short term. The regulations also enhance the company’s global supply chain of premium brands and products, and expand economics both domestically and abroad. The changes were made when the president of Colombia accepted and signed into effect revisions to existing Colombian cannabis laws. Revisions now allow for the sale and export of raw cannabis materials, including dried flower, to international markets. In addition, Colombian cultivators are now positioned to be leading suppliers to the global cannabis market. The revised regulations also permit the manufacturing, sale and export of ingestible cannabinoid products in Colombia, providing near-term revenue potential for Flora’s Kasa Wholefoods division. “This legislative update immediately accelerates Flora’s ability to generate revenue through the sale of our cannabis flower to international markets, as noted by our first international supply agreement. Having the ability to export our high-margin, high-quality cannabis flower – in addition to selling cannabinoid ingestible products – will meaningfully impact our growth and revenue generation,” Flora Growth Chief Revenue Officer Jason Warnock stated in the news release. “We are very excited to leverage our existing product portfolio and distribution channels to quickly deliver these new products to Colombians and our international partners.”

In addition, Argus Research, an independent investment research firm, released an Equity Research Report coverage on Flora Growth. The report noted that FLGC leverages cost-effective cannabis cultivation in Colombia and supplies cannabis as well as its derivatives for an expanding range of products, including cosmetics, pharmaceuticals, food and beverages, and hemp-based textiles. The report noted that FLGC’s Colombian cultivation operation benefits from favorable weather and produces harvest year-round, with costs lower than other Colombian producers. “In our view, Flora Growth is well positioned to participate in a global cannabis market that BDS Analytics projects will reach $56 billion by 2026, up from $21 billion in 2020,” the report states.

To view the full research report, visit  https://cnw.fm/QDrbM

To view the full press releases, visit https://cnw.fm/el5Cj and https://cnw.fm/UCzYf

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Pioneering Future-Looking Ideals and Products

Grapefruit USA (OTCQB: GPFT), a fully licensed premier manufacturer and distributor in the legal cannabis marketplace, is committed to being an industry leader by using science and technology to create truly disruptive products for both the recreational and medicinal cannabis marketplace. GPFT recently announced that it is accepting cryptocurrency as payment for its full-spectrum THC Hourglass time-release technology-powered products through its newly launched e-commerce platform, joining other leaders in the cannabis space in paving the way. A recent article reads, “Grapefruit is building a well-earned reputation for pioneering future-looking ideals and products. The company’s flagship product features cutting-edge science and technology that solves the age-old problem of THC and other cannabinoids not being easily absorbed through the skin. Grapefruit’s Hourglass topical cream uses patented micro-sized particles to slowly deliver THC and a wide range of cannabinoids through skin topical administration. No other topical cream product in the market provides users with the holistic benefits of the range of cannabinoids found in Hourglass, including THC+CBD, CBN, CBG, Delta8, THCV and CBE.”

To view the full article, visit https://cnw.fm/Z7C8D

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.